3Bar Biologics

About:

3Bar Biologics delivers a sustainable microbe inoculant system that helps farmers increase crop yield.

Website: http://www.3barbiologics.com/

Top Investors: S2G Ventures, Village Capital, SVG Ventures, Rev1 Ventures, Queen City Angels

Description:

3Bar Biologics is a bioscience company based in Columbus, OH. The firm is dedicated to applying disruptive technologies to create ecologically sound products that sustainably increase yields and protect farmer’s investments in land and seed. 3Bar’s first product is Bio-YIELD, an all-natural, sustainable microbe inoculant system. Bio-YIELD was first introduced to the market in 2014 serving eastern Corn Belt growers. We will broaden to the global market as we generate supporting data for additional markets. Scientists at The Ohio State University invested more than 15 years of research to produce the discovery process that identified the unique beneficial bacteria that are the foundation of this organic solution for increasing yields in corn, soybean, wheat, and other crops.

Total Funding Amount:

$2.4M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Columbus, Ohio, United States

Founded Date:

2013-01-01

Contact Email:

info(AT)3barbiologics.com

Founders:

Bruce Caldwell

Number of Employees:

11-50

Last Funding Date:

2021-11-09

IPO Status:

Private

Industries:

© 2025 bioDAO.ai